TruBridge, Inc.
General ticker "TBRG" information:
- Sector: Health Care
- Industry: Medical - Healthcare Information Services
- Capitalization: $307.6M (TTM average)
TruBridge, Inc. follows the US Stock Market performance with the rate: 46.1%.
Estimated limits based on current volatility of 0.0%: low 26.24$, high 26.25$
Factors to consider:
- Total employees count: 1500 as of 2024
- Top business risk factors: Limited hospital market saturation, Subscription model transition, Acquisition/divestiture risks, Customer reluctance to implement solutions, Geopolitical risks
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [14.22$, 25.86$]
- 2026-12-31 to 2027-12-31 estimated range: [12.21$, 22.72$]
Financial Metrics affecting the TBRG estimates:
- Positive: with PPE of 8.6 at the end of fiscal year the price was low
- Positive: 6.62 < Operating cash flow per share per price, % of 11.52
- Positive: -5.34 < Operating profit margin, % of 6.01
- Negative: negative Industry operating income (median)
- Positive: -14.27 < Investing cash flow per share per price, % of -4.59
- Negative: negative Industry operating cash flow (median)
- Positive: Industry inventory ratio change (median), % of -0.17 <= -0.15
- Positive: -3.72 < Return on assets ratio (scaled to [-100,100]) of 1.07
Short-term TBRG quotes
Long-term TBRG plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $339.44MM | $342.20MM | $346.84MM |
| Operating Expenses | $382.04MM | $335.57MM | $326.00MM |
| Operating Income | $-42.60MM | $6.63MM | $20.83MM |
| Non-Operating Income | $-11.78MM | $-17.10MM | $-16.96MM |
| Interest Expense | $12.52MM | $16.17MM | $12.32MM |
| R&D Expense | $38.83MM | $35.45MM | $32.56MM |
| Income(Loss) | $-54.38MM | $-10.47MM | $3.87MM |
| Taxes | $-8.59MM | $10.48MM | $-0.48MM |
| Net Income(Loss)* | $-45.79MM | $-20.44MM | $4.35MM |
| Stockholders Equity | $183.97MM | $167.07MM | $177.96MM |
| Inventory | $0.47MM | $0.77MM | $0.62MM |
| Assets | $431.78MM | $395.82MM | $402.53MM |
| Operating Cash Flow | $-0.52MM | $31.14MM | $36.97MM |
| Capital expenditure | $23.41MM | $19.10MM | $1.32MM |
| Investing Cash Flow | $-58.53MM | $5.12MM | $-14.72MM |
| Financing Cash Flow | $55.95MM | $-27.74MM | $-9.71MM |
| Earnings Per Share** | $-3.23 | $-1.43 | $0.30 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.